Viatris stock price at $11.28 remains resilient despite sector headwinds, supported by stable cash flow and sustained dividend yield of around 4.5%. “It’s really critical to be selective when it comes to buying dividend-paying stocks and chasing yield. Looking for the most yield-rich areas of the market can often lead you into troubled areas and dividend traps—companies that have a nice-looking yield that is ultimately unsustainable. You have to screen for dividend durability and reliability going forward.” Shares of the drug manufacturer have underperformed the broader market over the past year. VTRS stock has tanked 28.3% over the past 52 weeks and 31.9% on a YTD basis. In comparison, the S&P 500 Index ( $SPX ) has returned 8.2% over the past year but has dropped 4.7% in 2025. Viatris stock price hovered around $11.28 in the latest trading session, showing a mild -0.35% dip on moderate volume, hinting at investor caution ahead of Q2 earnings. Analysts project stable revenue streams, supported by diversification in generics and biosimilars.
